http://www.abnnewswire.net/podcast/en/29803/NEUREN_PHARMACEUTICALS_LIMITEDPortable audio versions of financial and company related announcements of interest to investors and analysts. More detailed / complete content can be found at ABN Newswire (http://www.abnnewswire.net)en-usCopyright 2004-2008, ABN Newswirenewsroom@abnnewswire.netSun, 7 Sep 2008 21:35:03 +0900Sun, 7 Sep 2008 21:35:03 +0900http://www.abnnewswire.net/images/logos/abnlogo.jpghttp://www.abnnewswire.net/index.asp6019Asia Business News - NEUREN PHARMACEUTICALS LIMITED PodcastABN NewswireABN Newswire PodcastsPortable audio versions of financial and company related announcements of interest to investors and analysts. More detailed / complete content can be found at ABN Newswire (http://www.abnnewswire.net)Copyright 2007 ABN NewswireABN Newswirenewsroom@abnnewswire.nethttp://www.abnnewswire.net/companies/en/29803/NEUREN_PHARMACEUTICALS_LIMITEDNEUREN PHARMACEUTICALS LIMITEDNeuren Pharmaceuticals Limited (ASX: NEU...Neuren Pharmaceuticals Limited (ASX: NEU) - Further Validation of NNZ-2566 as a Traumatic Brain Injury Treatment - Mr David Clarke, CEO; Boardroomradio is pleased to announce that Neuren Pharmaceuticals Limited (ASX: NEU) has published an audio file. The following presentation "Further Validation of NNZ-2566 as a Traumatic Brain Injury Treatment" is now available as an instant audio download to your computer. You may also transfer this information to your listening device as an IPod podcast. ... more http://boardroom-pc.streamguys.us/files/NEU/NEU20070214.mp3Wed, 14 Feb 2007 11:43:00 GMT+090000:10:00NEUREN PHARMACEUTICALS LIMITED